2010-2011 年加拿大安大略省人类对大环内酯类药物耐药的肺炎支原体。
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.
机构信息
Ontario Agency for Health Protection and Promotion,Toronto, Ontario, Canada.
出版信息
Emerg Infect Dis. 2013;19(9):1525-7. doi: 10.3201/eid1909.121466.
Abstract
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.
摘要
2011-2012 年期间，在加拿大安大略省从临床标本和分离株中检测到肺炎支原体的抗菌药物耐药率。在 91 份耐药肺炎支原体标本中，有 11 份（12.1%）携带与 23S rRNA 基因中大环内酯类耐药相关的核苷酸突变。没有肺炎支原体标本对氟喹诺酮类或四环素类药物耐药。
相似文献
1
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.2010-2011 年加拿大安大略省人类对大环内酯类药物耐药的肺炎支原体。
Emerg Infect Dis. 2013;19(9):1525-7. doi: 10.3201/eid1909.121466.
2
Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.韩国肺炎支原体大环内酯类耐药性，2000-2011 年。
Emerg Infect Dis. 2013 Aug;19(8):1281-4. doi: 10.3201/eid1908.121455.
3
Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.香港大环内酯类耐药肺炎支原体的出现与多位点可变数目串联重复序列分析4-5-7-2型中不断增加的大环内酯类耐药性有关。
J Clin Microbiol. 2015 Nov;53(11):3560-4. doi: 10.1128/JCM.01983-15. Epub 2015 Sep 2.
4
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.日本 2008-2015 年耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
5
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
6
Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.肺炎支原体肺炎抗菌治疗选择概述：关注大环内酯类耐药性
Clin Respir J. 2017 Jul;11(4):419-429. doi: 10.1111/crj.12379. Epub 2015 Oct 13.
7
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.6 岁男孩患耐大环内酯类肺炎支原体所致重症社区获得性肺炎。
Hong Kong Med J. 2011 Oct;17(5):407-9.
8
Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.2006 年至 2014 年斯洛文尼亚中部分离的呼吸道感染患者肺炎支原体的流行率、基因分型和大环内酯类耐药性。
Euro Surveill. 2015;20(37). doi: 10.2807/1560-7917.ES.2015.20.37.30018.
9
Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.2017-2023 年 COVID-19 大流行前后台湾儿童耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2024 Aug;30(8):1692-1696. doi: 10.3201/eid3008.231596.
10
Macrolide-Resistant Mycoplasma pneumoniae, United States.美国耐大环内酯类肺炎支原体
Emerg Infect Dis. 2015 Aug;21(8):1470-2. doi: 10.3201/eid2108.150273.
引用本文的文献
1
Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care.儿科社区获得性肺炎门诊抗生素处方质量。
BMC Pediatr. 2023 Oct 28;23(1):542. doi: 10.1186/s12887-023-04355-w.
2
Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.即时检测肺炎支原体的分子诊断，包括使用荧光淬灭探针聚合酶链反应检测大环内酯类药物敏感性。
PLoS One. 2021 Oct 14;16(10):e0258694. doi: 10.1371/journal.pone.0258694. eCollection 2021.
3
Molecular Detection and Evaluation of MLـ Resistance Associated with Mutation in 23S Gene among Iranian Patients with Respiratory Infections.伊朗呼吸道感染患者中与23S基因变异相关的大环内酯类耐药的分子检测与评估
Rep Biochem Mol Biol. 2020 Jul;9(2):223-229. doi: 10.29252/rbmb.9.2.223.
4
The Prevalence of in ML-Resistant Isolates to Clarithromycin in Patients with Respiratory Infections.呼吸道感染患者中耐大环内酯类肺炎支原体分离株对克拉霉素的耐药率
Rep Biochem Mol Biol. 2020 Jul;9(2):156-162. doi: 10.29252/rbmb.9.2.156.
5
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.儿童社区获得性肺炎中耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2020 Jul;26(7):1382-1391. doi: 10.3201/eid2607.200017.
6
Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study.与呼吸道感染相关的儿科危重症：一项单中心回顾性队列研究。
BMJ Paediatr Open. 2020 Apr 27;4(1):e000640. doi: 10.1136/bmjpo-2020-000640. eCollection 2020.
7
Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Pneumonia in Children.血清白细胞介素-17A在儿童难治性肺炎预测中的临床作用
Infect Drug Resist. 2020 Mar 12;13:835-843. doi: 10.2147/IDR.S240034. eCollection 2020.
8
An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.日本大环内酯类耐药株致成人严重威胁生命的肺炎支原体肺炎 1 例报告
BMC Infect Dis. 2019 Feb 28;19(1):204. doi: 10.1186/s12879-019-3846-1.
9
Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains.2011 年至 2017 年在大阪分离的肺炎支原体的遗传特征：大环内酯类耐药性检测率降低和 p1 基因 2 系菌株增加。
PLoS One. 2019 Jan 25;14(1):e0209938. doi: 10.1371/journal.pone.0209938. eCollection 2019.
10
Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016.2002-2016 年日本肺炎支原体多位点序列分型。
Emerg Infect Dis. 2018 Oct;24(10):1895-1901. doi: 10.3201/eid2410.171194.
本文引用的文献
1
Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.米诺环素或强力霉素对大环内酯类耐药肺炎支原体感染的快速疗效：2011 年日本儿童暴发疫情中的研究
Clin Infect Dis. 2012 Dec;55(12):1642-9. doi: 10.1093/cid/cis784. Epub 2012 Sep 12.
2
Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.美国中部地区大环内酯类耐药肺炎支原体感染率上升。
Pediatr Infect Dis J. 2012 Apr;31(4):409-0. doi: 10.1097/INF.0b013e318247f3e0.
3
Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.中国北京 40 株肺炎支原体分离株的抗生素敏感性及大环内酯类耐药株的分子分析。
Antimicrob Agents Chemother. 2012 Feb;56(2):1108-9. doi: 10.1128/AAC.05627-11. Epub 2011 Nov 21.
4
Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.执行摘要：儿童社区获得性肺炎（年龄大于 3 个月的婴儿和儿童）管理：由儿科传染病学会和美国传染病学会制定的临床实践指南。
Clin Infect Dis. 2011 Oct;53(7):617-30. doi: 10.1093/cid/cir625.
5
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
6
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.中国成人和青少年呼吸道感染肺炎支原体分离株中大环内酯类耐药率高。
Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.
7
A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.大环内酯类药物敏感与耐药肺炎支原体感染患儿的临床对比研究。
J Infect Chemother. 2009 Dec;15(6):380-3. doi: 10.1007/s10156-009-0715-7.
8
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.德国大环内酯类耐药肺炎支原体株的发生情况。
Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.
9
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.通过实时聚合酶链反应和熔解曲线分析直接在临床标本中检测到法国肺炎支原体对大环内酯类药物的耐药性增加。
J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.
10
Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae.人型支原体和解脲脲原体中16S rRNA突变的存在与体外对四环素敏感性降低有关。
J Antimicrob Chemother. 2008 Jun;61(6):1390-2. doi: 10.1093/jac/dkn118. Epub 2008 Mar 19.
Zotero 插件